Flare levels after intravitreal injection of brolucizumab for diabetic macular edema
Graefe's Archive for Clinical and Experimental Ophthalmology · 2024
DOI: 10.1007/s00417-024-06374-4 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Graefe's Archive for Clinical and Experimental Ophthalmology, 2024. Verfasst von Yushi Ichihashi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Eiheiji-Cho, Yoshida-Gun, Fukui-Ken, 910-1193, Japan. Hauptthemen laut MEDLINE: Intravitreal Injections, Macular Edema, Diabetic Retinopathy, Tomography, Optical Coherence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, University of Fukui.
Abstract (Originalsprache)
Purpose
This study aimed to evaluate anterior flare intensity (AFI) after intravitreal injection of brolucizumab (IVBr) in patients with diabetic macular edema (DME), and to identify the factors associated with the change of AFI after IVBr.
Methods
This prospective multicenter study was conducted at five sites in Japan for patients with DME who underwent a single IVBr. AFI and central retinal thickness (CRT) were measured using a laser flare meter and spectral-domain optical coherence tomography, respectively, at weeks 0 and 6.
Results
Sixty-five patients (phakia, 37 eyes; pseudophakia, 28 eyes) were enrolled. Six weeks after IVBr, CRT and best-corrected visual acuity significantly improved ( p < 0.0001). AFI ( p = 0.0003) and age ( p = 0.0054) were significantly higher in patients with pseudophakic eyes than those with phakic eyes. The AFI of the phakic eyes decreased after IVBr ( p = 0.043). As the AFI before injection is higher ( p = 0.0363) and the age is lower ( p = 0.0016), the AFI decreases after IVBr. There was a significant positive correlation between the rates of change in CRT and AFI ( p = 0.024).
Conclusion
After IVBr, AFI decreases in phakic eyes but not in pseudophakic eyes. The age, AFI and CRT before injection and changes of CRT are involved in the change in AFI after IVBr.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Eiheiji-Cho, Yoshida-Gun, Fukui-Ken, 910-1193, Japan.
- Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Eiheiji-Cho, Yoshida-Gun, Fukui-Ken, 910-1193, Japan. takamurayoshihiro@gmail.com.
- Department of Ophthalmology, Shinshu University School of Medicine, Matsumoto, Japan.
- Department of Ophthalmology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.
- Department of Ophthalmology, National Defense Medical College, Tokorozawa, Japan.
- Department of Ophthalmology, Mie University Graduate School of Medicine, Tsu, Japan.
Förderung
- Japan Society for the Promotion of Science
- University of Fukui
Zitieren
APA
Ichihashi, Y., Takamura, Y., Hirano, T., Shimura, M., Yoneda, K., Konno, K., Yamada, Y., Morioka, M., Gozawa, M., Matsumura, T., & Inatani, M. (2024). Flare levels after intravitreal injection of brolucizumab for diabetic macular edema. Graefe's Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-024-06374-4
Vancouver
Ichihashi Y, Takamura Y, Hirano T, Shimura M, Yoneda K, Konno K, et al. Flare levels after intravitreal injection of brolucizumab for diabetic macular edema. Graefe's Archive for Clinical and Experimental Ophthalmology. 2024. doi:10.1007/s00417-024-06374-4
BibTeX
@article{Ichihashi2024,
author = {Ichihashi, Yushi and Takamura, Yoshihiro and Hirano, Takao and Shimura, Masahiko and Yoneda, Keisuke and Konno, Keiichiro and Yamada, Yutaka and Morioka, Masakazu and Gozawa, Makoto and Matsumura, Takehiro and Inatani, Masaru},
title = {Flare levels after intravitreal injection of brolucizumab for diabetic macular edema},
journal = {Graefe's Archive for Clinical and Experimental Ophthalmology},
year = {2024},
doi = {10.1007/s00417-024-06374-4}
}
EUVIMED